Advertisement

Index by Author

June 2000; 23 (6)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ak, G

    • Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care June 2000 23:864-867; doi:10.2337/diacare.23.6.864a

  2. Anckaert, E

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  3. Anderson, C M

    • Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care June 2000 23:775-778; doi:10.2337/diacare.23.6.775

  4. Anderson, R M

    • The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care June 2000 23:739-743; doi:10.2337/diacare.23.6.739

  5. Ates, M

    • Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care June 2000 23:864-867; doi:10.2337/diacare.23.6.864a

B

  1. Baba, T

    • Trp64Arg polymorphism of the beta3-adrenergic receptor is not associated with diabetic nephropathy in Japanese patients with type 2 diabetes. Diabetes Care June 2000 23:862-863; doi:10.2337/diacare.23.6.862

  2. Beischer, W

    • Telemedicine in the management of pregnancy in type 1 diabetic women. Diabetes Care June 2000 23:863-864; doi:10.2337/diacare.23.6.863

  3. Bingham, S

    • Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care June 2000 23:726-732; doi:10.2337/diacare.23.6.726

  4. Blaauwwiekel, E E

    • Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care June 2000 23:750-753; doi:10.2337/diacare.23.6.750

  5. Bloomgarden, Z T

    • American Diabetes Association Annual Meeting, 1999: more on cardiovascular disease. Diabetes Care June 2000 23:845-852; doi:10.2337/diacare.23.6.845

  6. Bouter, K P

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  7. Bradley, C

    • The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability. Diabetes Care June 2000 23:875; doi:10.2337/diacare.23.6.875

  8. Bravenboer, B

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  9. Broch, M

    • Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care June 2000 23:831-837; doi:10.2337/diacare.23.6.831

  10. Buchanan, L

    • Hospital management of diabetic ketoacidosis in the U.K. Diabetes Care June 2000 23:871-872; doi:10.2337/diacare.23.6.871

  11. Burge, M R

    • Breath hydrogen testing identifies patients with diabetic gastroparesis. Diabetes Care June 2000 23:860-861; doi:10.2337/diacare.23.6.860

  12. Burton, B

    • Healthy people 2010: diabetes. Diabetes Care June 2000 23:853-855; doi:10.2337/diacare.23.6.853

  13. Buyukberber, S

    • Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care June 2000 23:864-867; doi:10.2337/diacare.23.6.864a

C

  1. Camps, M J

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  2. Cao, H

    • Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care June 2000 23:775-778; doi:10.2337/diacare.23.6.775

  3. Caragher, T E

    • Cautionary note regarding HbA1c methods predicting the clinical status of diabetic patients. Diabetes Care June 2000 23:867-869; doi:10.2337/diacare.23.6.867

  4. Casamitjana, R

    • Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care June 2000 23:831-837; doi:10.2337/diacare.23.6.831
    • Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies. Diabetes Care June 2000 23:874; doi:10.2337/diacare.23.6.874b

  5. Cianci, P

    • Consensus Development Conference on diabetic foot wound care: a randomized controlled trial does exist supporting use of adjunctive hyperbaric oxygen therapy. Diabetes Care June 2000 23:873-874; doi:10.2337/diacare.23.6.873

  6. Cigli, A

    • Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care June 2000 23:864-867; doi:10.2337/diacare.23.6.864a

  7. Classen, D C

    • Hemophilus vaccine associated with increased risk of diabetes: causality likely. Diabetes Care June 2000 23:872-873; doi:10.2337/diacare.23.6.872

  8. Classen, J B

    • Hemophilus vaccine associated with increased risk of diabetes: causality likely. Diabetes Care June 2000 23:872-873; doi:10.2337/diacare.23.6.872

  9. Coates, P A

    • Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care June 2000 23:813-819; doi:10.2337/diacare.23.6.813

  10. Collet, J T

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  11. Conget, I

    • Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies. Diabetes Care June 2000 23:874; doi:10.2337/diacare.23.6.874b

  12. Cook, C B

    • Diabetes in urban African-Americans. XIX. Prediction of the need for pharmacological therapy. Diabetes Care June 2000 23:820-825; doi:10.2337/diacare.23.6.820

  13. Coolens, J L

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  14. Costa, A

    • Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies. Diabetes Care June 2000 23:874; doi:10.2337/diacare.23.6.874b

D

  1. Day, N E

    • Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care June 2000 23:726-732; doi:10.2337/diacare.23.6.726

  2. Decochez, K

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  3. Dinesen, B

    • Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Diabetes Care June 2000 23:807-812; doi:10.2337/diacare.23.6.807

  4. Dohnal, J C

    • Cautionary note regarding HbA1c methods predicting the clinical status of diabetic patients. Diabetes Care June 2000 23:867-869; doi:10.2337/diacare.23.6.867

  5. Doi, K

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856
    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

E

  1. Eastman, R

    • Healthy people 2010: diabetes. Diabetes Care June 2000 23:853-855; doi:10.2337/diacare.23.6.853

  2. Eisma, W H

    • Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care June 2000 23:750-753; doi:10.2337/diacare.23.6.750

  3. El-Kebbi, I M

    • Diabetes in urban African-Americans. XIX. Prediction of the need for pharmacological therapy. Diabetes Care June 2000 23:820-825; doi:10.2337/diacare.23.6.820

  4. Eltabbakh, G H

    • Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care June 2000 23:801-806; doi:10.2337/diacare.23.6.801

  5. Evans, J M

    • Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. Diabetes Care June 2000 23:770-774; doi:10.2337/diacare.23.6.770

F

  1. Fabrin, J

    • Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care June 2000 23:796-800; doi:10.2337/diacare.23.6.796

  2. Fernández-Real, J M

    • Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care June 2000 23:831-837; doi:10.2337/diacare.23.6.831

  3. Fisher, B M

    • Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care June 2000 23:861-862; doi:10.2337/diacare.23.6.861

  4. Fitzgerald, J T

    • The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care June 2000 23:739-743; doi:10.2337/diacare.23.6.739

  5. Foster, B

    • Healthy people 2010: diabetes. Diabetes Care June 2000 23:853-855; doi:10.2337/diacare.23.6.853

  6. Frost, D

    • Telemedicine in the management of pregnancy in type 1 diabetic women. Diabetes Care June 2000 23:863-864; doi:10.2337/diacare.23.6.863

  7. Fukushima, M

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856
    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  8. Funnell, M M

    • The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care June 2000 23:739-743; doi:10.2337/diacare.23.6.739

G

  1. Gallina, D L

    • Diabetes in urban African-Americans. XIX. Prediction of the need for pharmacological therapy. Diabetes Care June 2000 23:820-825; doi:10.2337/diacare.23.6.820

  2. Galloway, P J

    • Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care June 2000 23:861-862; doi:10.2337/diacare.23.6.861

  3. Geerlings, S E

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  4. Gorus, F K

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  5. Groothoff, J W

    • Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care June 2000 23:750-753; doi:10.2337/diacare.23.6.750

  6. Grossman, P

    • Is there a glycemic threshold for impaired autonomic control? Diabetes Care June 2000 23:826-830; doi:10.2337/diacare.23.6.826

  7. Gutiérrez, C

    • Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care June 2000 23:831-837; doi:10.2337/diacare.23.6.831

H

  1. Hanley, A J

    • Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care June 2000 23:775-778; doi:10.2337/diacare.23.6.775

  2. Harris, M I

    • Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care June 2000 23:754-758; doi:10.2337/diacare.23.6.754

  3. Harris, S B

    • Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care June 2000 23:775-778; doi:10.2337/diacare.23.6.775

  4. Hegele, R A

    • Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care June 2000 23:775-778; doi:10.2337/diacare.23.6.775

  5. Heine, R J

    • Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care June 2000 23:765-769; doi:10.2337/diacare.23.6.765

  6. Hida, H

    • Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease. Diabetes Care June 2000 23:859-860; doi:10.2337/diacare.23.6.859

  7. Hoekstra, J B

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  8. Hoepelman, A I

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  9. Holstein, P E

    • Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care June 2000 23:796-800; doi:10.2337/diacare.23.6.796

  10. Holst, J J

    • Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Diabetes Care June 2000 23:807-812; doi:10.2337/diacare.23.6.807

I

  1. Isotani, H

    • Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease. Diabetes Care June 2000 23:859-860; doi:10.2337/diacare.23.6.859

J

  1. Jansz, A R

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

K

  1. Kakutani, S

    • Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease. Diabetes Care June 2000 23:859-860; doi:10.2337/diacare.23.6.859

  2. Kameoka, K

    • Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease. Diabetes Care June 2000 23:859-860; doi:10.2337/diacare.23.6.859

  3. Kanda, N

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856

  4. Kareinen, A

    • MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care June 2000 23:791-795; doi:10.2337/diacare.23.6.791
    • Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes. Diabetes Care June 2000 23:864; doi:10.2337/diacare.23.6.864b

  5. Kartnig, I

    • Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care June 2000 23:786-790; doi:10.2337/diacare.23.6.786

  6. Kawamoto, A

    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  7. Khaw, K T

    • Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care June 2000 23:726-732; doi:10.2337/diacare.23.6.726

  8. Kinoshita, H

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856

  9. Krarup, T

    • Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Diabetes Care June 2000 23:807-812; doi:10.2337/diacare.23.6.807

  10. Krzentowski, G

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  11. Kurzhals, R

    • Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care June 2000 23:813-819; doi:10.2337/diacare.23.6.813

L

  1. Laakso, M

    • MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care June 2000 23:791-795; doi:10.2337/diacare.23.6.791
    • Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes. Diabetes Care June 2000 23:864; doi:10.2337/diacare.23.6.864b

  2. Larsen, K

    • Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care June 2000 23:796-800; doi:10.2337/diacare.23.6.796

  3. Leese, G P

    • Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. Diabetes Care June 2000 23:770-774; doi:10.2337/diacare.23.6.770

  4. Lehmann, E D

    • Where is the evidence that radial artery tonometry can be used to accurately and noninvasively predict central aortic blood pressure in patients with diabetes? Diabetes Care June 2000 23:869-871; doi:10.2337/diacare.23.6.869

  5. Lehto, S

    • MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care June 2000 23:791-795; doi:10.2337/diacare.23.6.791
    • Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes. Diabetes Care June 2000 23:864; doi:10.2337/diacare.23.6.864b

  6. Links, T P

    • Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care June 2000 23:750-753; doi:10.2337/diacare.23.6.750

  7. Lipp, R W

    • HbA1c determination with high-performance liquid chromatography. Diabetes Care June 2000 23:874-875; doi:10.2337/diacare.23.6.874a

  8. Lomont, M E

    • Cautionary note regarding HbA1c methods predicting the clinical status of diabetic patients. Diabetes Care June 2000 23:867-869; doi:10.2337/diacare.23.6.867

  9. Luben, R N

    • Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care June 2000 23:726-732; doi:10.2337/diacare.23.6.726

  10. Luzio, S D

    • Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care June 2000 23:813-819; doi:10.2337/diacare.23.6.813

M

  1. MacDonald, T M

    • Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. Diabetes Care June 2000 23:770-774; doi:10.2337/diacare.23.6.770

  2. Madsbad, S

    • Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Diabetes Care June 2000 23:807-812; doi:10.2337/diacare.23.6.807

  3. Mann, J I

    • Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care June 2000 23:733-738; doi:10.2337/diacare.23.6.733

  4. Marrero, D G

    • The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care June 2000 23:739-743; doi:10.2337/diacare.23.6.739

  5. Matsushita, K

    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  6. Meijer, J W

    • Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care June 2000 23:750-753; doi:10.2337/diacare.23.6.750

  7. Mollema, E D

    • Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care June 2000 23:765-769; doi:10.2337/diacare.23.6.765

  8. Morris, A D

    • Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. Diabetes Care June 2000 23:770-774; doi:10.2337/diacare.23.6.770

  9. Muggeo, M

    • Capture-recapture method in the epidemiology of type 2 diabetes: a contribution from the Verona Diabetes Study. Diabetes Care June 2000 23:759-764; doi:10.2337/diacare.23.6.759

N

  1. Nagasaka, S

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856
    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  2. Nagata, I

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856
    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  3. Nakai, Y

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856
    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  4. Nakajima, S

    • Trp64Arg polymorphism of the beta3-adrenergic receptor is not associated with diabetic nephropathy in Japanese patients with type 2 diabetes. Diabetes Care June 2000 23:862-863; doi:10.2337/diacare.23.6.862

  5. Nakasone, M

    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  6. Netten, P M

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  7. Nicolle, L E

    • Asymptomatic bacteriuria in diabetic women. Diabetes Care June 2000 23:722-723; doi:10.2337/diacare.23.6.722

O

  1. Oakes, S

    • Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care June 2000 23:726-732; doi:10.2337/diacare.23.6.726

  2. Ooyama, Y

    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  3. Oriola, J

    • Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care June 2000 23:831-837; doi:10.2337/diacare.23.6.831

  4. Owens, D R

    • Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care June 2000 23:813-819; doi:10.2337/diacare.23.6.813

P

  1. Paterson, K

    • Hospital management of diabetic ketoacidosis in the U.K. Diabetes Care June 2000 23:871-872; doi:10.2337/diacare.23.6.871

  2. Phillips, L S

    • Diabetes in urban African-Americans. XIX. Prediction of the need for pharmacological therapy. Diabetes Care June 2000 23:820-825; doi:10.2337/diacare.23.6.820

  3. Pipeleers, D G

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  4. Poehlman, E T

    • Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care June 2000 23:801-806; doi:10.2337/diacare.23.6.801

  5. Pouwer, F

    • Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care June 2000 23:765-769; doi:10.2337/diacare.23.6.765

  6. Pratley, R E

    • Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care June 2000 23:779-785; doi:10.2337/diacare.23.6.779

  7. Pulkkinen, A

    • MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care June 2000 23:791-795; doi:10.2337/diacare.23.6.791
    • Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes. Diabetes Care June 2000 23:864; doi:10.2337/diacare.23.6.864b

R

  1. Ricart, W

    • Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care June 2000 23:831-837; doi:10.2337/diacare.23.6.831

  2. Richart, C

    • Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care June 2000 23:831-837; doi:10.2337/diacare.23.6.831

  3. Roller, R E

    • HbA1c determination with high-performance liquid chromatography. Diabetes Care June 2000 23:874-875; doi:10.2337/diacare.23.6.874a

  4. Ruta, D A

    • Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. Diabetes Care June 2000 23:770-774; doi:10.2337/diacare.23.6.770

S

  1. Sakai, M

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856
    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  2. Sandhofer, F

    • Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care June 2000 23:786-790; doi:10.2337/diacare.23.6.786

  3. Sargeant, L A

    • Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care June 2000 23:726-732; doi:10.2337/diacare.23.6.726

  4. Sari, R

    • Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care June 2000 23:864-867; doi:10.2337/diacare.23.6.864a

  5. Sasaki, I

    • Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease. Diabetes Care June 2000 23:859-860; doi:10.2337/diacare.23.6.859

  6. Savli, H

    • Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care June 2000 23:864-867; doi:10.2337/diacare.23.6.864a

  7. Schade, D S

    • Breath hydrogen testing identifies patients with diabetic gastroparesis. Diabetes Care June 2000 23:860-861; doi:10.2337/diacare.23.6.860

  8. Schnedl, W J

    • HbA1c determination with high-performance liquid chromatography. Diabetes Care June 2000 23:874-875; doi:10.2337/diacare.23.6.874a

  9. Semple, C G

    • Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care June 2000 23:861-862; doi:10.2337/diacare.23.6.861

  10. Sevinc, A

    • Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care June 2000 23:864-867; doi:10.2337/diacare.23.6.864a

  11. Sherwood, A

    • Is there a glycemic threshold for impaired autonomic control? Diabetes Care June 2000 23:826-830; doi:10.2337/diacare.23.6.826

  12. Sima, A A

    • Does insulin play a role in cardiovascular autonomic regulation? Diabetes Care June 2000 23:724-725; doi:10.2337/diacare.23.6.724

  13. Sites, C K

    • Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care June 2000 23:801-806; doi:10.2337/diacare.23.6.801

  14. Smit, A J

    • Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care June 2000 23:750-753; doi:10.2337/diacare.23.6.750

  15. Snoek, F J

    • Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care June 2000 23:765-769; doi:10.2337/diacare.23.6.765

  16. Spitzer, D

    • Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care June 2000 23:786-790; doi:10.2337/diacare.23.6.786

  17. Staudach, A

    • Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care June 2000 23:786-790; doi:10.2337/diacare.23.6.786

  18. Stepan, V M

    • HbA1c determination with high-performance liquid chromatography. Diabetes Care June 2000 23:874-875; doi:10.2337/diacare.23.6.874a

  19. Stephenson, C L

    • Breath hydrogen testing identifies patients with diabetic gastroparesis. Diabetes Care June 2000 23:860-861; doi:10.2337/diacare.23.6.860

  20. Stolk, R P

    • Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care June 2000 23:744-749; doi:10.2337/diacare.23.6.744

  21. Surwit, R S

    • Is there a glycemic threshold for impaired autonomic control? Diabetes Care June 2000 23:826-830; doi:10.2337/diacare.23.6.826

  22. Sutherland, W H

    • Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care June 2000 23:733-738; doi:10.2337/diacare.23.6.733

T

  1. Taniguchi, A

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856
    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  2. Tasaki, T

    • Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease. Diabetes Care June 2000 23:859-860; doi:10.2337/diacare.23.6.859

  3. Tataranni, P A

    • Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care June 2000 23:779-785; doi:10.2337/diacare.23.6.779

  4. Thaler, L M

    • Diabetes in urban African-Americans. XIX. Prediction of the need for pharmacological therapy. Diabetes Care June 2000 23:820-825; doi:10.2337/diacare.23.6.820

  5. Thomson, G A

    • Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care June 2000 23:861-862; doi:10.2337/diacare.23.6.861

  6. Tinbergen, J P

    • Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care June 2000 23:813-819; doi:10.2337/diacare.23.6.813

  7. Tits, J

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  8. Toft-Nielsen, M B

    • Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Diabetes Care June 2000 23:807-812; doi:10.2337/diacare.23.6.807

  9. Tokuyama, K

    • Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension. Diabetes Care June 2000 23:856-857; doi:10.2337/diacare.23.6.856
    • Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels. Diabetes Care June 2000 23:857-858; doi:10.2337/diacare.23.6.857

  10. Toth, M J

    • Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care June 2000 23:801-806; doi:10.2337/diacare.23.6.801

  11. Turk, H M

    • Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care June 2000 23:864-867; doi:10.2337/diacare.23.6.864a

  12. Tuttle, M S

    • Breath hydrogen testing identifies patients with diabetic gastroparesis. Diabetes Care June 2000 23:860-861; doi:10.2337/diacare.23.6.860

U

  1. Upritchard, J E

    • Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care June 2000 23:733-738; doi:10.2337/diacare.23.6.733

V

  1. van der Ploeg, H M

    • Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care June 2000 23:765-769; doi:10.2337/diacare.23.6.765

  2. Van Gaal, L

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  3. van Sonderen, E

    • Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care June 2000 23:750-753; doi:10.2337/diacare.23.6.750

  4. Vendrell, J

    • Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care June 2000 23:831-837; doi:10.2337/diacare.23.6.831

  5. Verlato, G

    • Capture-recapture method in the epidemiology of type 2 diabetes: a contribution from the Verona Diabetes Study. Diabetes Care June 2000 23:759-764; doi:10.2337/diacare.23.6.759

  6. Viitanen, L

    • MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care June 2000 23:791-795; doi:10.2337/diacare.23.6.791
    • Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes. Diabetes Care June 2000 23:864; doi:10.2337/diacare.23.6.864b

  7. Vilsbøll, T

    • Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Diabetes Care June 2000 23:807-812; doi:10.2337/diacare.23.6.807

  8. Vinicor, F

    • Healthy people 2010: diabetes. Diabetes Care June 2000 23:853-855; doi:10.2337/diacare.23.6.853

  9. Violett, J L

    • Breath hydrogen testing identifies patients with diabetic gastroparesis. Diabetes Care June 2000 23:860-861; doi:10.2337/diacare.23.6.860

W

  1. Wareham, N J

    • Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care June 2000 23:726-732; doi:10.2337/diacare.23.6.726

  2. Watkins, L L

    • Is there a glycemic threshold for impaired autonomic control? Diabetes Care June 2000 23:826-830; doi:10.2337/diacare.23.6.826

  3. Weets, I

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

  4. Weitgasser, R

    • Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care June 2000 23:786-790; doi:10.2337/diacare.23.6.786

  5. Welch, A

    • Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care June 2000 23:726-732; doi:10.2337/diacare.23.6.726

  6. Weyer, C

    • Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care June 2000 23:779-785; doi:10.2337/diacare.23.6.779

  7. Winnock, F

    • High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care June 2000 23:838-844; doi:10.2337/diacare.23.6.838

Z

  1. Zajc, M

    • Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care June 2000 23:786-790; doi:10.2337/diacare.23.6.786

  2. Ziemer, D C

    • Diabetes in urban African-Americans. XIX. Prediction of the need for pharmacological therapy. Diabetes Care June 2000 23:820-825; doi:10.2337/diacare.23.6.820

  3. Zinman, B

    • Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care June 2000 23:775-778; doi:10.2337/diacare.23.6.775

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement